Science Exchange, the world’s leading SaaS-enabled marketplace for outsourced research and development (R&D), announced today that Mark Currie, Ph.D., President and Chief Scientific Officer of Cyclerion, has joined the Science Exchange Board of Directors. Dr. Currie’s experience includes over thirty years in drug discovery and development, spanning leadership roles at Ironwood, Sepracor, and Monsanto/Searle.
“We are honored to add Mark to Science Exchange’s Board of Directors at this inflection point in our company’s growth,” said Elizabeth Iorns, Ph.D., founder and CEO of Science Exchange. “He brings first-hand experience with implementing innovative technology to set new standards for R&D speed in the industry.”
“Mark’s biotech industry experience is an invaluable resource for Science Exchange,” said Casper de Clercq, Science Exchange Board Member and General Partner at Norwest Venture Partners. “Mark’s insights will augment Science Exchange’s transformative effect on outsourced R&D being implemented by the company’s pharma and biotech clients.”
Cyclerion was recently named in the top 5 most promising new life sciences companies by BioSpace. Prior to his leadership at Cyclerion, Dr. Currie was senior vice president, chief scientific officer and president of R&D at Ironwood, where he pioneered the discovery and development of linaclotide and other GI therapeutic candidates. Before Ironwood, Dr. Currie led groups at Sepracor and at Monsanto/Searle, which produced several high-impact therapeutics, including LUNESTA® and CELEBREX®.
“I look forward to joining the Science Exchange team in helping R&D organizations worldwide accelerate R&D,” said Dr. Currie. “As a client, I appreciate the power of the Science Exchange platform to enhance productivity, maintain quality and compliance, and reduce risks, so that we may more rapidly advance innovative medicines to patients.”
Can your organization transform R&D to make a greater impact?
The top-performing experts and tips for R&D success — all in one book.
Learn which CROs, CMOs, and academic labs performed best in frequently requested categories, such as chemical synthesis and nucleic acid services. We’ve aggregated data from our platform to bring you a resource to help you Change Science™.